Biotech · Private company
SK Life Science, Inc.
Track this companyFree. Adds SK Life Science, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials193 recruiting or active
Pipeline programs23From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline23
- CarisbamatePhase 3 · SeizuresClinicalTrials.gov · fetched Nov 12, 2026
- CenobamatePhase 3 · Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- CenobamatePhase 3 · Primary Generalized EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- XcopriPhase 3 · Partial EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- YKP3089Phase 3 · Partial EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- SKL27969Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- AlprazolamPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Bupropion PillPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- CarisbamatePhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- CarisbamatePhase 1 · Lennox Gastaut SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- CenobamatePhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- CenobamatePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- CenobamatePhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Cenobamate 200Mg Tab FastedPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Cenobamate Oral Suspension FedPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Cenobomate Oral Suspension FastedPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- midazolamPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Omeprazole PillPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- SKL24741Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- SKL35501Phase 1 · Selected Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- SKL35502Phase 1 · Selected Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Warfarin PillPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- CenobamateFocal Onset SeizureClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials19
- SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid TumorsPHASE1 · RECRUITING · started Aug 19, 2026ClinicalTrials.gov NCT07812805 · fetched Nov 12, 2026
- Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset EpilepsyPHASE4 · ACTIVE_NOT_RECRUITING · started Oct 14, 2024ClinicalTrials.gov NCT06453213 · fetched Nov 12, 2026
- A Randomized, Open-label, Three-way Crossover Study to Evaluate the Relative Bioavailability of 200 Mg Cenobamate Administered OrallyPHASE1 · COMPLETED · started Sep 27, 2022ClinicalTrials.gov NCT05572255 · fetched Nov 12, 2026
- Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors PatientsPHASE1_PHASE2 · TERMINATED · started Sep 12, 2022ClinicalTrials.gov NCT05388435 · fetched Nov 12, 2026
- Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and AdultsPHASE3 · RECRUITING · started Apr 28, 2022ClinicalTrials.gov NCT05219617 · fetched Nov 12, 2026
- Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) SeizuresPHASE3 · COMPLETED · started Jan 10, 2022ClinicalTrials.gov NCT05067634 · fetched Nov 12, 2026
- Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset SeizuresPHASE1 · COMPLETED · started May 27, 2021ClinicalTrials.gov NCT04903314 · fetched Nov 12, 2026
- Bioavailability and Food Effect Study of Cenobamate as an Oral Suspension and TabletPHASE1 · COMPLETED · started Dec 21, 2020ClinicalTrials.gov NCT04690751 · fetched Nov 12, 2026
- Bioavailability and Food Effect Study of 3 Types of CarisbamatePHASE1 · COMPLETED · started Aug 27, 2020ClinicalTrials.gov NCT04520360 · fetched Nov 12, 2026
- Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study of SKL24741 in Healthy SubjectsPHASE1 · COMPLETED · started Feb 13, 2020ClinicalTrials.gov NCT04505397 · fetched Nov 12, 2026
- Cenobamate Open-Label Extension Study for YKP3089C025PHASE3 · COMPLETED · started Aug 13, 2019ClinicalTrials.gov NCT03961568 · fetched Nov 12, 2026
- Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut SyndromePHASE1 · COMPLETED · started May 3, 2019ClinicalTrials.gov NCT04062981 · fetched Nov 12, 2026
- Carisbamate in Adult & Pediatric Subjects With Lennox-Gastaut SyndromePHASE1 · COMPLETED · started Feb 7, 2019ClinicalTrials.gov NCT03731715 · fetched Nov 12, 2026
- Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC SeizuresPHASE3 · COMPLETED · started Oct 3, 2018ClinicalTrials.gov NCT03678753 · fetched Nov 12, 2026
- A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug UsersPHASE1 · COMPLETED · started Mar 8, 2017ClinicalTrials.gov NCT03509285 · fetched Nov 12, 2026
- Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug InteractionsPHASE1 · COMPLETED · started Feb 22, 2017ClinicalTrials.gov NCT03234699 · fetched Nov 12, 2026
- Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresPHASE3 · COMPLETED · started Aug 3, 2016ClinicalTrials.gov NCT02535091 · fetched Nov 12, 2026
- A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresPHASE2 · COMPLETED · started Jul 31, 2013ClinicalTrials.gov NCT01866111 · fetched Nov 12, 2026
- Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset SeizuresPHASE2 · COMPLETED · started Jul 6, 2011ClinicalTrials.gov NCT01397968 · fetched Nov 12, 2026